The global blood culture test market was valued at around US$ 4.4 Billion at the end of 2021. The market is projected to register a 4.9% CAGR and top a valuation of US$ 7.2 Billion by 2032.
High incidence of bloodstream infections, increasing adoption rate, and growing awareness among patients are expected to uplift the blood culture test market growth.
The microbiological culture of blood is known as blood culture, and it is used to identify infections that are spreading via the bloodstream. Early detection of blood infections is essential to avoid further consequences because the majority of blood infections are brought by bacteria entering the bloodstream through the lungs, skin, urine, or gastrointestinal system. Among the infections that spread through the bloodstream are septicemia and bacteremia. The results of the culture test can help to identify the particular microorganisms causing the infection and suggest treatment options.
Attributes
Details
Blood Culture Test Market Value in 2021
US$ 4.4 Billion
Blood Culture Test Market Value in 2032
US$ 7.2 Billion
Blood Culture Test Market CAGR (2022 to 2032)
4.9%
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
What are the Major Drivers Boosting the Demand for Blood Culture Test Market?
A major factor driving the demand for blood culture tests is the increasing incidence of sepsis and other blood-related clinical conditions. Expanding opportunities for the blood culture tests market will be brought by the higher approval rate of new products such as consumables and instruments for diagnosing Bloodstream Infections (BSI). Furthermore, Bloodstream Infections is a global concern and many people affected with this disorder will further need blood culture tests for identification will increase market expansion in the forecasted period.
The growing aging population and advancement in medical technologies, government awareness resulting in the rising government initiatives, and awareness among people in developed as well as developing countries all are factors that will boost the market expansion of the blood culture tests market.
Which Region Shows Strong Growth Potential in the Blood Culture Test Market?
The established economy of North America is anticipated to drive demand for blood culture tests, followed by Europe and the Asian region. In North America technically advanced healthcare infrastructure, high patient awareness, and significant healthcare spending all are contributing factors to market expansion in this region. Furthermore, advanced Medtech techniques like electro-spray ionization and Bac Spectrum assay increase the growth of the market.
Furthermore, rising disease incidences, favorable government initiatives, and investment in research and development regions are expected to experience rapid growth in the blood culture test market in the European regions. Moreover, Latin America and the East and South Asia regions are likely to experience sustainable growth in the forecast period due to the increasing population.
Find your sweet spots for generating winning opportunities in this market.
Who are the Key Players in the Blood Culture Test Market?
Some of the market players operating in the blood culture tests market are bioMérieux SA, Roche Diagnostics, Becton Dickinson, Siemens AG, Thermo Fisher Scientific Inc., Bruker Corporation, Cepheid, Alere Inc., Nanosphere, Danaher Corporation, and Abbott Laboratories.
Scope of Report
Report Attributes
Details
Growth Rate
CAGR of 4.9% from 2022 to 2032
Base Year for Estimation
2021
Historical Data
2012 to 2021
Forecast Period
2022 to 2032
Qualitative Units
Revenue in USD Billion, and CAGR from 2022 to 2032
Report Coverage
Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis
Segment Covered
Product
Technology
Application
End User
Region
Region Covered
North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East & Africa
Key Countries Profiled
USA
Canada
Brazil
Mexico
Germany
United Kingdom
France
Spain
Italy
China
Japan
South Korea
Malaysia
Singapore
Australia
New Zealand
GCC Countries
South Africa
Israel
Key Players
bioMérieux SA
Roche Diagnostics
Becton Dickinson
Siemens AG
Thermo Fisher Scientific Inc.
Bruker Corporation
Cepheid, Alere Inc.
Nanosphere
Danaher Corporation
Abbott Laboratories
Customization
Available Upon Request
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Key Segments Covered in the Blood Culture Test Industry Survey
By Product:
Consumables
Instruments
Software and Services
By Technology:
Culture-based Technology
Molecular Technology
Microarray
PCR
PNA-FISH
Proteomic Technology
Others
By Application:
Bacterial Infections
Fungal Infections
Mycobacterial Infections
By End-User:
Hospital Laboratories
Reference Laboratories
Research Laboratories
Others
By Region:
North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East and Africa
Frequently Asked Questions
The global blood culture test market is anticipated to register a CAGR of 4.9% during the forecast period.
The top players in the global blood culture test market are bioMérieux SA, Roche Diagnostics, Becton Dickinson, Siemens AG, Thermo Fisher Scientific Inc., Bruker Corporation, Cepheid, Alere Inc., Nanosphere, Danaher Corporation, and Abbott Laboratories.
- Request for Table of Contents -
Complete the form below and we'll get back to you shortly
